Screener
Outlook Therapeutics, Inc. OTLK Q2 2025 earnings
Reported August 14, 2025 · Before market open
Revenue$1.5MMiss by $4.3M
EPS-$0.44Miss by $0.02
Revenue estimate$5.8M
EPS estimate-$0.42
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Outlook Therapeutics, Inc. report Q2 2025 earnings?
- Outlook Therapeutics, Inc. (OTLK) reported Q2 2025 earnings on August 14, 2025 before market open.
- What were Outlook Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Outlook Therapeutics, Inc. reported revenue of $1.5M and eps of $-0.44 for Q2 2025.
- Did Outlook Therapeutics, Inc. beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $5.8M by $4.3M. EPS missed the consensus estimate of $-0.42 by $0.02.
- How did Outlook Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 47.0% from $-0.83.
- Where can I find Outlook Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-25-078622) and the 10-Q periodic report (0001558370-25-011588) directly on SEC EDGAR. The filing index links above go to sec.gov.
